Patent · US Active

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

US11384339B2 · kind B2 · utility

13Cited by

15References

13Claims

0Family size

Assignee

Wisconsin Alumni Research Foundation · US

Inventors

Yoshihiro Kawaoka · Middleton, US
Gabriele Neumann · Madison, US
Makoto Ozawa · Tachikawa, JP

Key dates

Filing date	Nov 25, 2019
Grant date	Jul 12, 2022
Priority date	—
Expiry date	Nov 25, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a recombinant biologically contained influenza virus that is a PB2 knockout virus, e.g., one that is useful to generate a multivalent vaccine, and methods of making and using that virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.